Back to Resource Library
KNO

Knobloch Syndrome

Overview

Knobloch syndrome is a rare autosomal recessive disorder caused by mutations in COL18A1 (encoding collagen XVIII/endostatin), characterized by high myopia, vitreoretinal degeneration, retinal detachment, and occipital encephalocele. The retinal phenotype is severe, with early-onset retinal detachment and progressive visual loss. The occipital encephalocele may be subtle or absent in some patients, making the diagnosis challenging.

Genetics

Caused by COL18A1 mutations affecting collagen XVIII, a component of basement membranes and precursor to endostatin. Autosomal recessive.

GeneLocusInheritanceNotes
COL18A121q22.3ARCollagen type XVIII alpha-1; endostatin precursor; sole known cause

Clinical Presentation

Neonatal/Infancy

  • Occipital encephalocele (variable)
  • High myopia
  • Lens dislocation in some

Childhood

  • Vitreoretinal degeneration
  • Retinal detachment
  • Progressive visual loss

Diagnosis

  • Neuroimaging: Occipital encephalocele or scalp defect
  • Ocular examination: High myopia, vitreous degeneration
  • Genetic testing: COL18A1 sequencing

Current Research & Treatment

No specific treatments available. Surgical repair of retinal detachment and encephalocele. Genetic counseling for families.

Active Clinical Trials

The following active clinical trials are investigating treatments for Knobloch Syndrome. Trial status and enrollment may change; always verify directly on ClinicalTrials.gov.

Disclaimer: ClearSight is not affiliated with any clinical trial sponsor or organization. Trial information is sourced from ClinicalTrials.gov and public press releases for educational purposes only. Always consult a qualified healthcare professional before considering trial participation.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Genetic testing and clinical management should be performed by qualified healthcare professionals, including ophthalmologists and genetic counselors.